Event Details

While the outbreak of COVID-19 is significantly impacting the healthcare industry in China amid all the uncertainties caused by the epidemic spread, the opportunities also lurk.


Please join the AmCham Shanghai and European Union Chamber of Commerce in China joint healthcare webinar on April 1st, from 10:30 am-11:45 am. Jens Ewert, Industry Leader of China Life Science and Health Care at Deloitte will share the findings from their survey in response to the COVID-19 outbreak among 104 leading pharma companies in China. Key predictions for the healthcare sector in 2020 will be provided.


Executives from the healthcare industry will join the panel afterward to discuss how their companies are coping during this time of turbulent change and the opportunities they are observing now. The panel will be moderated by Greg Scott, Chair of Healthcare Committee at AmCham Shanghai.


Agenda:

10:30 am: Welcome

10:35 am: Opening remarks by Ker Gibbs, AmCham Shanghai President

10:45 am: Presentation by Jens Ewert

11:05 am: Panel discussion /Q&A

11:40 am: Closing

11:45 am: Event ends


After your registration is complete, you should receive a confirmation email from EventBank with a link to "Go to the Webinar". Please click this link immediately to register on the GoToWebinar website to avoid login issues later.


Please note, if you plan to join using your mobile phone you will need to download the GoToWebinar App from your app store.

Speakers

  • Jens Ewert (Partner at Deloitte)

    Jens Ewert

    Partner at Deloitte

    Jens Ewert, is a Partner with Deloitte based in Shanghai office and China Firm since 2002, and has over 30 years of working experience in the professional services. For many years already, he is a member of Deloitte China Eastern Region Management team.

    His responsibilities include our services to Multinational Clients (MNC) in China and some selected Clients across the Asia Pacific region. This covers our Advisory services (Consulting, Financial Advisory, Tax&Legal and Risk Advisory) as well as our Audit & Assurance.

    Since mid-2019, Jens has also taken on the role as Deloitte China Life Science & Health Care Leader – covering an industry team comprising over 600+ partners and professionals focused on working with Life Science & Pharma companies as well as Healthcare and related services groups.

    Jens is currently a Board member at the EUCCC Shanghai Chapter, and the National Chair of the Investment Working group since 2016 at the EU Chamber in China. He also was a member of the Board of Trustees at the French School in Shanghai starting in 2004 and the Chairman of the Board between 2007 until mid-2015.

    Throughout his career, other than China, he has been living and working in France, Hungary, the US, Vietnam and Indonesia.

    Jens holds German and French nationalities, and calls France – beyond Shanghai - his home. He received his education in France (Paris), University Paris Dauphine and the Institut des Sciences Politiques de Paris, and holds a CPA Australia license. He is a passionate Tennis and Golf player in Shanghai, when time permits.

    view more
  • David Xie (China Life Sciences & Healthcare Consulting Director of Deloitte)

    David Xie

    China Life Sciences & Healthcare Consulting Director of Deloitte

    David is a Director based in Shanghai. He was trained in Chemistry and Biophysics, has many years of R&D experience in academia as well as the biotech industry in the US before entering the consulting industry. In his consulting career, David worked frequently with life sciences clients on strategic and operational issues in R&D, product launch, market access, innovation, and organization change. He was the key author of a recent Deloitte China thought ware published “Opportunity and Influence for Localized Development – Pharmaceutical R&D Trends in China”.
    David has education background of MBA at MIT, Biophysics PhD from University of Chicago, and Chemistry bachelor from Peking University

    view more
  • Veronica Acurio (Vice President, Greater China Area at 3M Health Care Business Group)

    Veronica Acurio

    Vice President, Greater China Area at 3M Health Care Business Group

    In her current role as Area Vice President, Veronica is responsible for all of 3M’s Health Care Business in China, Taiwan and Hong Kong.

    Previously she was President and Managing Director of 3M Taiwan. Prior to that, she was the Global Platforms Director for the Medical Solutions Division. Veronica is a transformational and growth-driven business leader. Her successful results have been driven by her ability to influence stakeholders, quickly grasp business needs and create strategies to drive change. A strong leader who develops high performance teams, Veronica identifies the talents of her team and builds on those strengths – always encouraging stretch goals and risk-taking. Over the course of her career, she has successfully paired strategic and operational business experience with strong financial, sales and marketing functional experience. Her business and marketing expertise spans Market Research, New Product Development, Strategic Planning, Pricing, CRM, Portfolio Management, and Brand Management. Veronica began her 3M career in Peru, where she held positions of increasing responsibility in Finance, Sales, Sales Management, Country Business Leadership, Corporate Marketing & Public Affairs, and Customer Service. In 2002, Veronica joined 3M Corporate Marketing as Marketing and Strategic Planning Manager for Latin America and Africa. In 2004, she was appointed Global Marketing Operations Manager for 3M ESPE. In 2008, she was named Global Business Director for Restorative Dental Products, and in 2010 she assumed the responsibility of Global Business Director for C3SD Acute Care Business. In 2013, she was appointed Business Development Director, Health Care Business for Latin America. Veronica has been actively involved in supporting women’s leadership and community programs. In 2019, She was the chair the American Heart Association chapter for women. Veronica holds a Business Administration degree in Marketing and Finance from the Universidad del Pacifico, in Lima, Peru.

    view more
  • Valtero Canepa (General Manager at Shanghai Bracco Sine Pharmaceuticals Corp.)

    Valtero Canepa

    General Manager at Shanghai Bracco Sine Pharmaceuticals Corp.

  • Thomas Shao (Director of Government Affairs and Public Policy at Abbott China)

    Thomas Shao

    Director of Government Affairs and Public Policy at Abbott China

    With a Master’s Degree in International Management and a Bachelor’s Degree in Political Science, Thomas Shao started his career in Shanghai Municipal Commission of Commerce in 2000. He served as the Chief English Interpreter for Mayor of Shanghai for 7 years before he was promoted to Assistant Director for Foreign Investment Promotion Department in 2007. In 2012, he joined Evonik Degussa China as Senior Manager for Public Policy. In 2014, he joined Abbott as the Associate GA Director. Now he is
    GA Director of Abbott China, responsible for policy & strategy and crisis management as well as supporting manufacturing operations in China.

    view more